longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Green Thumb Industries Inc.

GTBIF

7.4904.34% ( -0.340 )
Delay Closed: Sep 10, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 14.31, within the reasonable range, cheaper than 77.67% of the time in the past 5 years, and the industry ranks 20/258, the industry Median -1.41.

14.31xP/E
$7.83Stock price
$0.55Earnings per share
14.31xP/E
Stock price$7.83Earnings per share$0.55

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
31.75x
Typical range
13.74x–67.85x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
10.89x7.88%$197.08B
BMYUSBristol Myers Squibb
14.17x62.25%$131.57B
GSKUSGSK
15.38x6.56%$99.09B
UCBJYUSUCB S.A.
17.77x--$45.25B
HLNUSHaleon
18.74x2.92%$40.65B
OTSKYUSOtsuka Pharmaceutical
15.32x--$39.67B
DSNKYUSDaiichi Sankyo
19.03x--$31.97B
ZTSUSZoetis
11.49x6.81%$30.29B
ALPMYUSAstellas Pharma
11.10x--$25.87B
JAZZUSJazz Pharma
16.65x348.40%$15.66B
OPHLYUSOno Pharmaceutical
14.56x--$7.09B
INDVUSIndivior Pharmaceuticals
11.53x126.83%$4.10B
SNPHYUSSanten Pharmaceutical
15.18x--$3.75B
OGNUSOrganon
17.18x211.11%$3.59B
HRMYUSHarmony Biosciences
13.37x45.48%$2.42B
PBHUSPrestige Brands
13.41x7.48%$2.31B
GTBIFUSGreen Thumb Industries Inc.
14.31x--$1.81B
ANIPUSANI Pharma
15.95x49.55%$1.59B
PAHCUSPhibro Animal Health
14.98x26.75%$1.49B
OMERUSOmeros
11.24x1,880.00%$1.40B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.